The 5 -year survival rate is nearly 100%, and the efficacy data of more than 6,000 patients with early prostate cancer disclosed at the Fudan Cancer Hospital

"The 5 -year survival rate of early patients was nearly 100%..." A few days ago, the 2022 Prostate Cancer Academic Week and Pujiang Prostate Cancer Summit Forum came from the news. More than 6,000 patients with early prostate cancer patients treated at the hospital. Through the "swelling techniques" of original prostate cancer root treatment surgery, the urology team of the oncology hospital is accurately treating tumors, while protecting the function as much as possible, improving the quality of patients' survival, and making prostate cancer is no longer a difficult disease.

Professor Ye Dingwei introduced that my country is a major prostate cancer country. The latest statistics of the World Health Organization show that there are more than 110,000 new cases of prostate cancer in 2020. Compared with developed countries in Europe and the United States, patients with prostate cancer in my country have shown the characteristics of high advanced proportion, low 5 -year survival rate, and poor quality of life. Although early patients obtained the opportunity of cure surgery, the loss of functional loss of postoperative urinary incontinence was still the biggest "heart disease" of their dyeing surgery. With the improvement of living standards, more and more patients not only pursue good treatment effects, but also hope to get better quality of life.

"Double Surgical Robot" help, accurately crack the patient's sleep

The prostate resection surgery is easy to damage multiple functions, so prostate cancer has become the "hidden of male words" for many men. Whether to undergo cure surgery has become a dilemma.

How to protect the function of patients with prostate cancer to a greater extent? Test the surgical skills of many urological doctors. In order to achieve accurate surgery of prostate cancer, Professor Ye Dingwei led the team to target international advanced surgery technical concepts, independently innovated and summarized surgical techniques suitable for the characteristics of the physical structure of the country, and developed "swelling techniques" for prostate cancer surgery. While five key surgical steps, the patient's functional recovery and postoperative safety are guaranteed while maximizing the root treatment of tumors.

Professor Ye's team combined with the most advanced robot surgery system through this original "swelling technique" to successfully solve the pain to eliminate the pain, retain the function, and restore normal life for a large number of early prostate cancer patients. Regarding the positive and local violations that are concerned by local advanced patients, Professor Ye Dingwei's team uses the excellent amplification effect of the robot surgery imaging system to put the small prostate more than 10 times more. Removal routes, combined with various bladder urethral reconstruction and structural protection surgery techniques, enable patients to achieve better results.

Professor Ye Dingwei said: "At present, the second -generation Da Vinci surgery robot in our hospital has been installed and entered into the" dual machine "era. The measure of the measures to make the appointment of robotics greatly shortened, and changed the embarrassing situation of "less machines and more planes, one machine difficult to find ', and providing more patients with precise tumor control and functional protection brought by the precise minimally invasive robotic minimally invasive."

The superb surgical skills of the Surgical Cancer Surgery Team of Fudan Tumor have been widely recognized by the industry. The team will also lead the clinical research of domestic surgical robots. China's autonomous property rights operating robot combined with Professor Ye's "swelling technique" of the Chinese people will be merged and merged in depth. Blinds a higher quality surgery.

Migrate prostate cancer can also get surgery opportunities, and the international stage issues "Chinese Voice"

Migrate prostate cancer tradition is mainly drug treatment. Most opinions are considered that the value of prostate lesions is limited. Can patients with metastatic prostate cancer also achieve good results through surgery? Professor Ye Dingwei has carried out a rigorous random control clinical study with many years of clinical experience.

Professor Ye Dingwei said: "This study first confirmed that patients with prostate cancer only need to metastasize the lesion ≤5 and have no internal organs. The total survival rate has been increased by 18%. The results of this research have also been published by the top journal "European Urology" magazine in the international urinary tumor field, which also marks that this Chinese urinary tumor treatment moves to the new step. "

For the first time, this study clarified the surgical resection of prostate lesions in patients with metastatic prostate cancer, which can significantly increase the survival rate of patients. Clinical treatment strategy of metastatic prostate cancer.

Multi -disciplinary experts empower, allowing top new drugs at home and abroad to cover patients with each staging

The purpose of clinical research is to analyze and clarify the safety and effectiveness in clinical diagnosis and treatment of new drugs or new treatments or new treatments, represent the new direction of future diagnosis and treatment, and provide patients with optimized diagnosis and treatment plans. As a leader in the field of urology clinical research, Professor Ye Dingwei has led more than 70 clinical research in the field of urinary tumors, so that countless urinary tumor patients can get better listing drugs. Because of his authority, Professor Ye Dingwei is the editor -in -chief of CSCO prostate cancer guidelines and CACA prostate cancer guidelines. The use of new drugs and technology has always been in line with international standards.

Professor Ye Dingwei said: "Urinary tumor innovation drugs and new technologies have started late, and there is little power to speak on the international stage. For many years, the urology team of the oncology hospital has deeply cultivated the field of prostate cancer. For the few urinary tumor centers covered by clinical research covered by the early, middle, and advanced stages, the most accurate diagnosis and treatment solutions are formulated through the multidisciplinary expert team of urinary tumors. Experts follow up the treatment effect throughout the process, evaluate the treatment plan in a timely manner, and timely deal with side effects, so that prostate cancer patients have the opportunity to live longer and live better. Patients with lack of effective drug treatment and family economic conditions provide opportunities to enjoy the most advanced treatment drugs and diagnosis and treatment techniques in the country, which greatly reduces patients' pain and economic burden.

---

Author: Tang Wenjia Zhu Yu

Edit: Tang Wenjia

Editor in charge: Fan Liping

---

*Wenhui exclusive manuscript, please indicate the source for reprinting.

- END -